|
Report Date : |
23.06.2012 |
IDENTIFICATION DETAILS
|
Name : |
REGIONAL CENTRE FOR BIOTECHNOLOGY |
|
|
|
|
Registered
Office : |
180, Udyog Vihar, Phase I, Gurgaon – 122016, Haryana |
|
|
|
|
Country : |
|
|
|
|
|
Year of
Establishment : |
2009 |
|
|
|
|
Capital
Investment / Paid-up Capital : |
Not Divulged |
|
|
|
|
Legal Form : |
Government Organisation |
|
|
|
|
Line of Business
: |
The Regional Centre for Biotechnology (RCB) is a newly established
institution of education, training and research in the National Capital
Region (NCR) of · Biomedical Science · Bioengineering and Devices · Biochemical and Biophysical Sciences · Climate science, agriculture and environment · Biotechnology Regulatory Affairs, IPR and Policy |
|
|
|
|
No. of Employees
: |
50 (Approximately) |
RATING & COMMENTS
|
MIRA’s Rating : |
A (63) |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
Status : |
Excellent |
|
|
|
|
Payment Behaviour : |
Regular |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Subject is an established Institution of Education, Training and
Research by the Department of Biotechnology. It is a Government of India company
and associated with UNESCO. It focuses on biotechnology growth in the
Asia-Pacific region. Due to the nature of its operations, the financial details are not
made available. The company can be considered good for business dealings at usual trade
terms and conditions. |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – September 30, 2011
|
Country Name |
Previous Rating (30.06.2011) |
Current Rating (30.09.2011) |
|
India |
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
INFORMATION PARTED BY (GENERAL DETAILS)
|
Name : |
Mr. Vashist |
|
Designation : |
Manager |
|
Contact No.: |
91-124-2848800 |
|
Date : |
20.06.2012 |
LOCATIONS
|
Registered Office : |
180, Udyog Vihar, Phase I, Gurgaon – 122016, Haryana, India |
|
Tel. No.: |
91-124-2848800 |
|
Website : |
|
|
|
|
|
Branches : |
Located at: Faridabad (under constriction) |
MANAGEMENT
|
FACULTY |
|
|
Name |
|
|
|
|
|
Name : |
|
|
|
|
|
Name : |
|
|
|
|
|
Name : |
|
|
|
|
|
Name : |
|
|
|
|
|
Name : |
|
|
|
|
|
ADJUNCT FACULTY |
|
|
Name : |
|
|
|
|
|
YOUNG INVESTIGATORS |
|
|
Name : |
Jasmita Gill |
|
|
|
|
Name : |
Alka Dwevedi |
|
|
|
|
Name : |
|
|
|
|
|
Name : |
|
|
|
|
|
Name : |
|
|
|
|
|
Name : |
|
|
|
|
|
Name : |
BUSINESS DETAILS
|
Line of Business : |
The Regional Centre for Biotechnology (RCB) is a newly
established institution of education, training and research in the National
Capital Region (NCR) of Delhi by the Department
of Biotechnology, Government of India under an agreement with UNESCO. · Biomedical Science · Bioengineering and Devices · Biochemical and Biophysical Sciences ·
Climate science, agriculture and environment ·
Biotechnology Regulatory Affairs, IPR and
Policy |
|
|
|
|
Terms : |
|
|
Selling : |
Cash, Credit |
|
|
|
|
Purchasing : |
Cash, Credit |
GENERAL INFORMATION
|
Customers : |
End Users |
|
|
|
|
No. of Employees : |
50 (Approximately) |
|
|
|
|
Student : |
13 (Approximately) |
|
|
|
|
Bankers : |
State Bank of India, Gurgaon – 122016 |
|
|
|
|
Facilities : |
-- |
|
|
|
|
Banking
Relations : |
-- |
|
|
|
|
Associates/Subsidiaries : |
NA |
CAPITAL STRUCTURE
NOT DIVULGED
FINANCIAL DATA
[all figures are
in Rupees Millions]
NOT DIVULGED
Note : Sole Proprietory and Partnership concerns are
exempted from filing their financials with the Government Authorities or
Registry.
LOCAL AGENCY FURTHER INFORMATION
|
Check
List by Info Agents |
Available
in Report (Yes / No) |
|
1)
Year of Establishment |
Yes |
|
2)
Locality of the firm |
Yes |
|
3)
Constitutions of the firm |
Yes |
|
4)
Premises details |
No |
|
5)
Type of Business |
Yes |
|
6)
Line of Business |
Yes |
|
7)
Promoter's background |
-- |
|
8)
No. of employees |
Yes |
|
9)
Name of person contacted |
Yes |
|
10)
Designation of contact person |
Yes |
|
11)
Turnover of firm for last three years |
No |
|
12)
Profitability for last three years |
No |
|
13)
Reasons for variation <> 20% |
-- |
|
14)
Estimation for coming financial year |
No |
|
15)
Capital in the business |
No |
|
16)
Details of sister concerns |
No |
|
17)
Major suppliers |
No |
|
18)
Major customers |
No |
|
19)
Payments terms |
Yes |
|
20)
Export / Import details (if applicable) |
No |
|
21)
Market information |
-- |
|
22)
Litigations that the firm / promoter involved in |
-- |
|
23)
Banking Details |
Yes |
|
24)
Banking facility details |
No |
|
25)
Conduct of the banking account |
-- |
|
26)
Buyer visit details |
-- |
|
27)
Financials, if provided |
No |
|
28)
Incorporation details, if applicable |
-- |
|
29)
Last accounts filed at ROC |
-- |
|
30)
Major Shareholders, if available |
-- |
WEBSITE DETAILS:
The Regional Centre for Biotechnology (RCB) is a newly established
institution of education, training and research in the National Capital Region
(NCR) of Delhi by the Department of Biotechnology, Government of India under an
agreement with UNESCO. RCB is designed to be a centre of excellence in
biotechnology with intimate contributions from the countries of the region and
academic institutions from the rest of the world. It provides a meeting place
where innovation, enterprise, and industrial development will germinate. This
Centre would be beneficial to all countries in the region including India in
carrying out biotechnology research of highest caliber and developing
knowledge-rich highly skilled human resource. Biotechnology being essentially
global, the partnerships are as much within as across countries. Association
with UNESCO essentially expands the opportunities to create world class
education and research and provides seeds of global cooperation.
Who they are
Regional Centre for Biotechnology (RCB), an institution of education, training and research is established by the Department of Biotechnology, Government of India under the auspices of UNESCO. The Centre will focus on cooperatively working towards shared biotechnology growth in the Asia-Pacific Region. Regional interactions in biotechnology will promote co-operation amongst the countries to develop necessary infrastructure and capacity building for economic benefit of their societies. The Centre would be beneficial in developing knowledge rich, highly skilled human resource to all countries in the region. RCB will be part of the Biotech Science Cluster (BSC) and will operate in synergy with the other institutions in the Cluster.
Mandate of the Centre is to provide a platform for biotechnology education, training and research at the interface of multiple disciplines. The programmes of the Centre will be designed to create opportunities for students to engage in multi-disciplinary research where they learn biotech science while integrating engineering, medicine and science, to provide solutions for human and animal health, agriculture and environment technologies.
Interim Laboratories
The interim laboratories of the Centre have been set up
within the National Capital Region (NCR) Delhi in a 20,000 sq ft building at 180,
Udyog Vihar Phase I, Gurgaon (Haryana) adjacent to the South Delhi area.
Permanent Campus
The permanent campus of the Centre is coming up within the Biotech Science Cluster (BSC) on a 200 acre plot of land, at Faridabad in the National Capital Region. The Cluster will facilitate synergizing high value resources and infrastructure, coordinated development and maximize societal benefits.
Major activities planned
The Centre will carry out and promote multi-disciplinary innovative research in biotech sciences. Contemporary research at the interface of disciplines with integration of science, engineering and medicine and emphasis on the relevance to the regional societies is being undertaken. Broad range of areas synergizing with biotech science will be pursued:
· Biomedical Science
· Bioengineering and Devices
· Biochemical and Biophysical Sciences
· Climate science, agriculture and environment
· Biotechnology Regulatory Affairs, IPR and Policy
Biomedical Science is a continually changing and dynamic
subject and is therefore enormously challenging and involves analyses of life
processes to gain an understanding of health and the methods for diagnosing,
analyzing and treating diseases. Areas within the above domains being currently
initiated include analyses of complex diseases for identification of
intervention points and development of knowledge-based drug discovery
approaches. Application of the principles of engineering and natural sciences
to tissues, cells and molecules could be described as Bioengineering and is
closely linked with modern biotechnology. It advances knowledge from the
molecular to the organ systems level and aids in the development of innovative
biologics, materials, devices and informatics approaches for prevention,
diagnosis and treatment of disease as well as improvement of crops and quality
of the biosphere. Nanoscience for biotechnology, wherein the emphasis would be
on design of novel nano-devices for bio-sensing, diagnostic and therapeutic
utility would be among the priority areas. Biochemical and Biophysical studies
at the molecular and cellular level and as part of systems biology foster
progress in comprehending the mechanisms underlying the control of cellular
physiological processes and the consequences of its perturbation. Climate change,
agriculture and environment are interrelated processes taking place on a global
scale. Integration of climate models with design strategies for transgenic
crops and environmental impact of climate change using mathematical as well as
physical approaches are also being envisioned to be priority areas. A major
aspect of biotech revolution concerns addressing regulatory and IPR issues as
well as policy analyses. The inter-relationship of policy and IPR exists along
with every aspect of biology and therefore this domain will grow
synergistically along with other multidisciplinary areas.
Academic Programmes
The design and processes of the education at this Centre
will be such that it will generate technology savvy solution finders/creators; science
entrepreneurs/knowledge economy entrepreneurs and research and development
leaders.
Interdisciplinary Ph D programme of the Regional Centre for Biotechnology aims
at producing a highly specialized cadre of scientists capable of translating
laboratory research to clinical practice with detailed knowledge of both
medicine and practice of scientific investigations. The goal of this
interdisciplinary Ph D programme is to educate students at the interface of
engineering, physical sciences and the biomedical sciences via a flexible
structure that permits explorations at the intersections of these disciplines.
Post-doctoral programmes for the young scientists below the age of 35 are being
developed, in the areas of active interest at the Centre, for mentoring talent
towards the leadership role in biotech science.
The center will be open to industry for enhancing their skills in specific
areas. Domain-specific programmes will also be designed for people from basic
sciences in nanotechnology, implants and devices, vaccine development and stem
cell biology in order to create a cadre of highly specialized scientists for
technology development in these areas. Interdisciplinary education and training
programme at the Centre will be constantly evolving, and will be a source of
new ideas and methods in teaching in biotechnology.
An important focus of expertise building will be regulation, product
development, scale up, manufacturing science and bio-entrepreneurship. The
Centre will also provide user friendly opportunities for career development and
will also be open to industry for enhancing their skills in specific areas
required for career advancement. The Centre will have adequate infrastructure
for scale-up and process engineering.
PRESS RELEASES
Department of Science and Technology
UNESCO Regional
Centre for Biotechnology
The Government of India and the UNESCO fully realizing the need of training and education for generating interdisciplinary human resource relevant to biotechnology, took a joint decision to establish the Regional Centre for research, training and education in biotechnology under the auspices of UNESCO. Union Minister for Science and Technology and Earth Sciences, Shri Kapil Sibal today announced the setting up of UNESCO Regional Centre for Biotechnology at its first meeting of the Board of Governors held in New Delhi. The centre will come up in Faridabad, Haryana by next year.
Interacting with the media on the occasion, Shri Sibal said that the Centre would be beneficial to all countries in the region including India in developing knowledge-rich highly skilled human resource, harmonization of policies and procedures in biotechnology and indirectly promoting trade. Biotechnology being essentially global, the partnerships are as much within as across countries. The Centre will create a place from which many such partnerships will emerge. A Centre of education, training and research in biotechnology with intimate contributions from the countries of the region and academic institutions from the rest of the world and provides a meeting place where innovation, enterprise, and industrial development will germinate.
Secretary, DBT, Dr. Bhan said that the primary focus of the UNESCO Regional Center for Biotechnology is to provide high quality human resource of an interdisciplinary nature and in areas of acute shortage. As education and training of world class quality requires a research milieu, the research in the proposed center will also be an interface of multiple disciplines and focused on technology development. He said that the educational programmes of the UNESCO Centre are designed to create opportunities for students to engage in research where they learn the tools by integrating science, engineering and medicine to provide health care solutions for human and animal sector, for agriculture and environment technologies.
Mr. M. Barbosa, Deputy Director General, UNESCO and Smt. Bhaswati Mukherjee, Ambassador and Permanent Representative of India to UNESCO also spoke on the occasion.
The unique activities at the Centre will include Science and Technology expertise building for physicians intending to enter biology; short term medicine exposure to biologists and engineers by networking through local hospitals/ medical schools and short term training in platform technologies for skill development in existing personnel. Specialized domain-specific programmes will also be created in new opportunity areas such as Cell and Tissue Engineering, Nano and biosciences, synergy of information technology and advanced biomaterials to create a cadre of highly specialized people who integrate across disciplines. An important focus of expertise building will be regulation, product development, scale up, manufacturing science and bio-entrepreneurship. The Centre will also provide user friendly opportunities for career development and will also be open to industry for enhancing their skills in specific areas required for career advancement. The Centre will have adequate infrastructure for scale-up and process engineering.
The Department of Biotechnology (DBT), Govt of India has decided to set up a unique Health Biotech Science Cluster (HBSC) at Faridabad on a 200 acre plot of land in the National Capital Region (NCR) and will co-locate the UNESCO Regional Centre for Biotechnology (URCB) and the Translational Health Science Technology Institute (THSTI). A number of other related Centres to be co-located at the cluster are at conceptual stage. The Cluster will facilitate synergizing high value resources and infrastructure, coordinated development and maximize societal benefits.
The Mandate of the UNESCO Regional Centre for Biotechnology is to provide a platform for interdisciplinary research, education and training in order to create human resources required at the biotech interface of engineering, chemistry, physics and medicine and to empower human resources critical for a wide range of biotech needs and to seek knowledge-based innovative and context-specific biotechnology solutions
The design and processes of the education at this Centre will be such that it will generate technology savvy solution finders/creators; science entrepreneurs/ knowledge economy entrepreneurs and R and D leaders.
Interdisciplinary Ph. D. programme of the UNESCO Regional Centre for Biotechnology aims at producing a highly specialized cadre of scientists capable of translating laboratory research to clinical practice with detailed knowledge of both medicine and practice of scientific investigations. The goal of this interdisciplinary Ph.D. programme is to educate students at the interface of engineering, physical sciences and the biomedical sciences via a flexible structure that permits explorations at the intersections of these disciplines.
The center will be open to industry for enhancing their skills in specific areas. Domain-specific programmes will also be designed for people from basic sciences in nanotechnology, implants and devices, vaccine development and stem cell biology in order to create a cadre of highly specialized scientists for technology development in these areas.
The Centre will be able to produce highly trained and skilled human resource in interdisciplinary areas of biotechnology, and a new cadre of professionals with expertise in relevant areas, enabling them towards delivery of low cost, effective and penetrative technologies in health care, agriculture and veterinary sciences. The centre’s success in delivering the objectives will need vital support from states of the region and UNESCO’s support in terms of both finances and programme development.
CMT REPORT (Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts,
1] INFORMATION ON
DESIGNATED PARTY
No records exist designating subject or any of its beneficial owners,
controlling shareholders or senior officers as terrorist or terrorist
organization or whom notice had been received that all financial transactions
involving their assets have been blocked or convicted, found guilty or against
whom a judgement or order had been entered in a proceedings for violating
money-laundering, anti-corruption or bribery or international economic or
anti-terrorism sanction laws or whose assets were seized, blocked, frozen or
ordered forfeited for violation of money laundering or international
anti-terrorism laws.
2] Court Declaration :
No records exist to suggest that subject is
or was the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper
payments to government officials for engaging in prohibited transactions or
with designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction
registered against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No
available information exist that suggest that subject or any of its principals
have been formally charged or convicted by a competent governmental authority
for any financial crime or under any formal investigation by a competent
government authority for any violation of anti-corruption laws or international
anti-money laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on Corporate
Governance to identify management and governance. These factors often have been
predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions between
a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws,
regulations or policies that prohibit, restrict or otherwise affect the terms
and conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.56.99 |
|
|
1 |
Rs.88.97 |
|
Euro |
1 |
Rs.71.57 |
INFORMATION DETAILS
|
Report Prepared
by : |
SDA |
SCORE & RATING EXPLANATIONS
|
SCORE FACTORS |
RANGE |
POINTS |
|
HISTORY |
1~10 |
5 |
|
PAID-UP CAPITAL |
1~10 |
7 |
|
OPERATING SCALE |
1~10 |
8 |
|
FINANCIAL CONDITION |
|
|
|
--BUSINESS SCALE |
1~10 |
8 |
|
--PROFITABILIRY |
1~10 |
7 |
|
--LIQUIDITY |
1~10 |
7 |
|
--LEVERAGE |
1~10 |
7 |
|
--RESERVES |
1~10 |
7 |
|
--CREDIT LINES |
1~10 |
7 |
|
--MARGINS |
-5~5 |
-- |
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
YES |
|
--LITIGATION |
YES/NO |
NO |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
YES |
|
--AFFILIATION |
YES/NO |
YES |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
|
TOTAL |
|
63 |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this report.
The assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
- |
NB |
New Business |
- |
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.